FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
about
Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activityFKBP51 and FKBP52 in signaling and diseaseChaperoning steroidal physiology: lessons from mouse genetic models of Hsp90 and its cochaperonesGlucocorticoids, epigenetic control and stress resilienceThe helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.Roles for the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, in feedback control of inflammatory gene expression and repression by dexamethasone.Molecular mechanisms of repeated social defeat-induced glucocorticoid resistance: Role of microRNAProlyl isomerases in gene transcriptionProgestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive- Associated Abnormal Uterine Bleeding.Corticosteroid-induced gene expression in allergen-challenged asthmatic subjects taking inhaled budesonide.Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational ImplicationsEpigenetic Biomarkers as Predictors and Correlates of Symptom Improvement Following Psychotherapy in Combat Veterans with PTSD.Neuroendocrinology of a Male-Specific Pattern for Depression Linked to Alcohol Use Disorder and Suicidal Behavior.Psychological stress as a modulator of functional recovery following spinal cord injury.Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51.Hsp90-binding immunophilins as a potential new platform for drug treatment.Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism.Biological relevance of Hsp90-binding immunophilins in cancer development and treatment.Sarcoidosis extent relates to molecular variability.Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.Regulation of store-operated calcium entry by FK506-binding immunophilinsCombination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signalingFKBP5 genotype interacts with early life trauma to predict heavy drinking in college studentsFKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone.Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity.The chaperone Hsp90 and PPIases of the cyclophilin and FKBP families facilitate membrane translocation of Photorhabdus luminescens ADP-ribosyltransferases.FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt.Examining FKBP5 mRNA expression in human iPSC-derived neural cells.Expression of FK506-binding protein 51 (FKBP51) in Mycosis fungoides.Androgen receptor reverts dexamethasone‑induced inhibition of prostate cancer cell proliferation and migration.Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice.Placental FKBP51 mediates a link between second trimester maternal anxiety and birthweight in female infantsDeletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoid-induced skin atrophy
P2860
Q26782111-8AD4FDA6-5300-4A21-A547-AADE5D9CEBBAQ26861304-26F39B6C-4725-48BB-B4B6-96043B71B1B3Q27011776-EFD8DC9E-19C4-44EB-A013-BDBE98AFB403Q28088692-807B9C6B-5A39-4DC4-A56E-F9065463BD80Q33633104-A3E4CBF7-C183-475F-AE82-E43D5CB3B5B2Q34413270-9558A17A-7949-40AB-9C64-D14E8C7749A3Q34765042-FFBD755B-2C39-4012-BFA1-E00118CD0466Q35561852-F9A40948-D7EF-4268-8CC3-4B50F43F76EBQ35799214-9D943F6E-F825-4BEF-B442-0D741A81A9F5Q36025336-E4030795-CA17-4961-8718-9E80541DB73FQ36366772-32268CDD-E2B8-42FF-92F6-93EAB846AFE2Q37201415-080E26C6-F72B-45C7-9B34-9F25DBC5A805Q37550094-C2D6EC85-EF03-4DA6-9AA8-986F7E64804DQ37705476-BD96F886-DB74-4BE1-A10A-2C34AA7C754AQ38006721-0012D89F-8157-4561-807E-38D115B8BB5BQ38097870-445F4C53-8FDE-449C-85BC-D414CF9A08D7Q38161940-979767F5-383F-453D-9559-F36B75C50AA3Q38371280-32CD4F04-354B-4B0A-B14C-2ACBD16CB13AQ38958413-CB8CFE19-E399-45E0-BC66-48219245ED01Q38964993-4B4456E4-C4DB-4510-8486-D33E49C7796FQ39200797-FFD46F79-0006-4799-9192-A8F5210948E9Q39223255-94A43381-423B-4B97-9B42-212A39B8C176Q40916830-3671792C-F0CF-4527-84F5-62F419F0C2EAQ41263478-7E6DA902-68C5-43D4-979D-F1215061981EQ41640775-C36AFB81-4E65-468A-8BE8-895BAAFA190FQ41882137-CA9AB853-9983-4746-AE5A-CA338519C9AEQ44816054-8826AED2-1201-45F3-AEF1-8C61215EE267Q47112399-9DD0AC1D-8BCB-4B30-A9D8-645671C6CABFQ47140676-254AEAAA-6D19-4F2E-BDF4-0C0606750314Q47699242-4680CEA1-A683-41C5-8563-A36B37329A02Q50047876-868FFD15-71E3-409E-A700-899D347BBD94Q53438486-0503191A-2CC9-4E4E-880C-45281FD88178Q57477057-F2EA4099-2379-4883-91FD-147B4056BF66Q58582621-0135D8AE-3B6C-409B-9613-DC18751D8CFF
P2860
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
@ast
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
@en
type
label
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
@ast
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
@en
prefLabel
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
@ast
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
@en
P2860
P1476
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.
@en
P2093
Edwin R Sanchez
P2860
P304
P356
10.1016/J.COPH.2011.04.012
P577
2011-05-11T00:00:00Z